Neurocrine Biosciences
NBIX
#1360
Rank
NZ$28.44 B
Marketcap
NZ$282.94
Share price
-10.08%
Change (1 day)
30.69%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend history for this company